Surgeon Slapped With 2 L Fine for Prescribing Inappropriate Medications

Published On: 19 Apr, 2023 11:54 PM | Updated On: 17 May, 2024 12:07 AM

Surgeon Slapped With 2 L Fine for Prescribing Inappropriate Medications

The National Consumer Disputes Redressal Commission (NCDRC) fined a Thane-based surgeon with Rs. 2 lacs for prescribing medicines for stress urinary incontinence (SUI)––without heeding the patient’s condition. 

The Apex Consumer Court observed that the patient was prescribed a systemic drug – Dolamide, an NSAID, despite the serum-creatinine signifying renal impairment. The NCDRC bench opined that a nephrologist’s opinion was warranted before any such prescription.

The patient had been operated on under Dr. Krishnakumar in 2006 for SUI. The NSAID was prescribed post-surgery. About six months later, the patient was detected with high blood pressure and was referred to a nephrologist who confirmed damage to both her kidneys due to NSAID use despite a serum-creatinine level of 2.67%. She was diagnosed with chronic kidney disease. 

The patient had been on hemodialysis (due to end-stage renal disease - ESRD) since 2008 when she lodged a complaint in the Maharashtra State Consumer Court. The doctor denied negligence on the basis of the fact that short-term Dolamide (containing Nimesulide) use cannot cause chronic renal failure.

The NCDRC bench stated that medical records suggested that Dolamide use precipitated renal damage in this patient, although the drug may not be liable for the ESRD and the eventual renal transplantation requirement. Nevertheless, not consulting a nephrologist before prescribing a Nimesulide-based medication to a known renal impairment patient was considered negligent on the surgeon’s part.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks